CinCor Pharma
Financial ratios & Valuation

Historical Multiples (2019 – 2021)

2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-76.19-16.88-11.25-13.46-46.53
Price/Sales ratio
N/AN/AN/AN/AN/A
Price/Book Value ratio
-75.45-13.78-8.892.28-44.61
Price/Cash Flow ratio
-84.86-21.60-18.37-18.70-53.23
Price/Free Cash Flow ratio
-84.86-21.60-18.37-18.67-53.23
Price/Earnings Growth ratio
N/A-0.04-0.220.00-0.02
Dividend Yield
N/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/A
Effective Tax Rate
2.01%0.16%0.04%N/A0.10%
Return on Assets
-41.37%-83.06%-35.68%-16.64%-62.21%
Return On Equity
99.02%81.65%79.01%-33.02%80.33%
Return on Capital Employed
-50.35%-106.11%-34.12%-15.90%-78.23%
Liquidity Ratios
Current Ratio
N/AN/AN/A51.95N/A
Quick Ratio
6.923.888.5251.315.40
Cash ratio
6.663.788.2528.735.22
Days of Sales Outstanding
N/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/A0.01N/A
Debt Equity Ratio
N/AN/AN/A0.01N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/A-51.28N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A
Company Equity Multiplier
-2.39-0.98-2.211.01-1.68
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.001
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/A